2-(4,5-Dichloro-6-oxopyridazin-1(6H)-yl)-N-(4-methyl-3-((4-methyl-1,4-diazepan-1-yl)sulfonyl)phenyl)acetamide

ID: ALA4875218

PubChem CID: 162728014

Max Phase: Preclinical

Molecular Formula: C19H23Cl2N5O4S

Molecular Weight: 488.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)Cn2ncc(Cl)c(Cl)c2=O)cc1S(=O)(=O)N1CCCN(C)CC1

Standard InChI:  InChI=1S/C19H23Cl2N5O4S/c1-13-4-5-14(23-17(27)12-26-19(28)18(21)15(20)11-22-26)10-16(13)31(29,30)25-7-3-6-24(2)8-9-25/h4-5,10-11H,3,6-9,12H2,1-2H3,(H,23,27)

Standard InChI Key:  HMSYSGKNOIHRNA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   12.2816   -4.6452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6982   -3.9327    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.8729   -3.9282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4133   -4.3452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4121   -5.1725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1269   -5.5852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8431   -5.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8403   -4.3416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1251   -3.9324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6987   -3.1080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6975   -5.5842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5532   -3.9264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2690   -4.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9819   -3.9210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2722   -5.1610    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6977   -4.3308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6977   -5.1546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4128   -5.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1265   -5.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1208   -4.3199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4052   -3.9138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3984   -3.0891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8322   -3.9021    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.8431   -5.5578    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.9629   -2.7505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7777   -1.9450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4464   -2.7489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2875   -1.2984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6289   -1.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1112   -1.2999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4681   -0.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  4  2  1  0
  2 10  1  0
  5 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  1  0
 21 22  2  0
 20 23  1  0
 19 24  1  0
 10 25  1  0
 25 26  1  0
 10 27  1  0
 26 28  1  0
 27 29  1  0
 28 30  1  0
 29 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4875218

    ---

Associated Targets(Human)

PRMT5 Tchem PRMT5/MEP50 complex (963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.40Molecular Weight (Monoisotopic): 487.0848AlogP: 1.82#Rotatable Bonds: 5
Polar Surface Area: 104.61Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.68CX Basic pKa: 7.07CX LogP: 1.38CX LogD: 1.21
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.69Np Likeness Score: -2.64

References

1. McKinney DC, McMillan BJ, Ranaghan MJ, Moroco JA, Brousseau M, Mullin-Bernstein Z, O'Keefe M, McCarren P, Mesleh MF, Mulvaney KM, Robinson F, Singh R, Bajrami B, Wagner FF, Hilgraf R, Drysdale MJ, Campbell AJ, Skepner A, Timm DE, Porter D, Kaushik VK, Sellers WR, Ianari A..  (2021)  Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor Interaction.,  64  (15.0): [PMID:34342224] [10.1021/acs.jmedchem.1c00507]

Source